Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Post by dr_jdion Apr 01, 2019 5:22pm

115 Views

Post# 29566296

This company is doomed to sit at .20+for the next 10 years

This company is doomed to sit at .20+ for the next 10 years. They are incompetent at bringing anything to market, and/or finding partrners to do so. They don't earn much from the core business, don't show a profit and probably won't for 10 years. There is no initiative to increase shareholder value.If I coulld this trash, I would.

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles